Crossref
Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential
Obesity Medicine · 2026-07 · 62 · 100718
DOI: 10.1016/j.obmed.2026.100718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Medicine, 2026-07. Verfasst von Ghanshyam Mapare und 1 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mapare, G., & Belemkar, S. (2026). Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential. Obesity Medicine, 62, 100718. https://doi.org/10.1016/j.obmed.2026.100718
Vancouver
Mapare G, Belemkar S. Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential. Obesity Medicine. 2026;62:100718. doi:10.1016/j.obmed.2026.100718
BibTeX
@article{Mapare2026,
author = {Mapare, Ghanshyam and Belemkar, Sateesh},
title = {Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential},
journal = {Obesity Medicine},
year = {2026},
volume = {62},
pages = {100718},
doi = {10.1016/j.obmed.2026.100718}
}
EUVIMED